LEPU BIO-B(02157): H shares fully tradable completed
Luopu Biology-B (02157) announced that 54.2684 million shares of unlisted shares have been converted into H shares as of ...
LEPU BIO-B (02157) announced that 54,268,400 unlisted shares have been converted to H shares on July 21, 2025, and the conversion of H shares will be listed on the Hong Kong Stock Exchange starting at 9:00 am on July 22, 2025.
Related Articles
The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.
Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).
CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.
The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.
Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).
CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.
RECOMMEND
Total Investment of 1.2 Trillion Yuan: Yarlung Zangbo Hydropower Project Commences, Creating Investment Opportunities in Water Conservancy, Power Grid, and Cement Sectors
21/07/2025
Another Major Order Secured for Humanoid Robots, Setting a Global Record
21/07/2025
Seven Ministries Jointly Release 11 Measures to Encourage Foreign-Invested Enterprises to Reinvest in China
21/07/2025
